CausalSentinel

Protein Dossier — CD8A (T-cell surface glycoprotein CD8 alpha chain)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Invasive mucinous ovarian cancer 0.271 0.0964 0.00497 Wald ratio 1 cis NA
Schizophrenia -0.0723 0.0265 0.00627 Wald ratio 1 cis NA
Diagnoses - main ICD10: K35 Acute appendicitis 0.188 0.0692 0.00645 Wald ratio 1 cis NA
Diagnoses - main ICD10: Z09 Follow-up examination after treatment for conditions other than malignant neoplasms 0.111 0.0422 0.00827 Wald ratio 1 cis NA
Alcohol intake frequency -0.0207 0.00855 0.0157 Wald ratio 1 cis NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast 0.0938 0.0412 0.023 Wald ratio 1 cis NA
Body mass index (BMI) -0.0126 0.00578 0.0295 Wald ratio 1 cis NA
Eye problems or disorders: Injury or trauma resulting in loss of vision -0.178 0.0906 0.0492 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter 0.115 0.0617 0.0632 Wald ratio 1 cis NA
Alzheimer’s disease -0.0758 0.0413 0.0661 Wald ratio 1 cis NA
Fractured bone site(s): Arm -0.118 0.0659 0.0723 Wald ratio 1 cis NA
Low grade serous ovarian cancer -0.217 0.123 0.0771 Wald ratio 1 cis NA
…and 58 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

34 association rows across 30 traits (34 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating CD8A levels (id: OID05124_OID21018) 9e-554 rs3020726 2 GCST90860677 no MR -> candidate analysis
Circulating CD8A levels (id: OID00772_OID21018) 2e-435 rs3020726 2 GCST90860107 no MR -> candidate analysis
Serum levels of protein CD8A 2e-122 rs3020726 1 GCST90089255 no MR -> candidate analysis
T-cell surface glycoprotein CD8 alpha chain levels 2e-100 rs3020726 2 GCST90249784 no MR -> candidate analysis
CD8A protein levels 4e-90 rs62146078 1 GCST90468655 no MR -> candidate analysis
Blood protein levels 7e-73 rs111976570 1 GCST006585 no MR -> candidate analysis
CD8 on CD28+ CD45RA+ CD8+ T cell 3e-65 rs938487 1 GCST90002119 no MR -> candidate analysis
T-cell surface glycoprotein CD8 alpha chain (analyte X5992.5 3e-49 rs3020726 1 GCST90426555 no MR -> candidate analysis
CD8 on naive CD8+ T cell 3e-46 rs35626322 1 GCST90002055 no MR -> candidate analysis
CD8 on CD8+ T cell 6e-43 rs3020726 1 GCST90002058 no MR -> candidate analysis
Cerebrospinal fluid protein CD8A levels 4e-42 rs3020726 1 GCST90944172 no MR -> candidate analysis
CD4+ CD8dim T cell %lymphocyte 1e-36 rs35706509 2 GCST90001610 no MR -> candidate analysis
…and 18 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 2798 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
tinea unguium 0.484 common-variant locus no MR -> candidate analysis
progressive supranuclear palsy 0.31 common-variant locus no MR -> candidate analysis
stroke disorder 0.128 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1.9e-09, LOEUF=1.44 — LoF-tolerant
GWAS Catalog 47 unique SNPs / 94 rows
ClinVar 239 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance